MODIA™ paper published in the Journal of Medical Internet Research Mental Health
Uppsala, Sweden – October 18, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announced the publication of a manuscript, “A Personalized, Interactive, Cognitive-Behavioral Therapy-Based Digital Therapeutic (MODIA™) for Adjunctive Treatment of Opioid Use Disorder: Development Study,” in the Journal of Medical Internet Research (JMIR) Mental Health. The paper outlines the development and features of the company´s new digital therapeutic, MODIA™. (Link to the article: https://mental.jmir.org/2021/10/e31173). MODIA™ was developed by Orexo in collaboration with GAIA AG, and, in July,